Sentinel Node Biopsy after Neoadjuvant Chemotherapy for Breast Cancer: Preliminary Experience with Clinically Node Negative Patients after Systemic Treatment

Sentinel Node Biopsy after Neoadjuvant Chemotherapy for Breast Cancer: Preliminary Experience with Clinically Node Negative Patients after Systemic Treatment

Sentinel lymph node biopsy (SLNB) following neoadjuvant treatment (NACT) has been questioned by many studies that reported heterogeneous identification (IR) and false negative rates (FNR). As a result, some patients receive axillary lymph node dissection (ALND) regardless of response to NACT, leadin...

Full description

Bibliographic Details
Main Authors: Alejandro Martin Sanchez, Daniela Terribile, Antonio Franco, Annamaria Martullo, Armando Orlandi, Stefano Magno, Alba Di Leone, Francesca Moschella, Maria Natale, Sabatino D’Archi, Lorenzo Scardina, Elena J. Mason, Flavia De Lauretis, Fabio Marazzi, Riccardo Masetti, Gianluca Franceschini
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Journal of Personalized Medicine
Subjects:
neoadjuvant chemotherapy
sentinel lymph node
breast cancer
systemic treatment
locally advanced breast cancer
mini-invasive treatment
Online Access:https://www.mdpi.com/2075-4426/11/3/172

Internet

https://www.mdpi.com/2075-4426/11/3/172

Similar Items